medline.ch Onkologie Gynäkologische Tumoren

	Association of Body Mass Index with Tumor-Infiltrating Lymphocytes and Treatment Response in Early HER2-Positive Breast Cancer. Int J Womens Health Sánchez Gómez R, Pérez-Míes B, Palacios J, Moreno Bueno G, Calvo I, Solorzano JL, Neria F, Fernandez-Abad M, González-Martínez S, García-Estevez L. PMID: 42239604 [PubMed - in process]
	AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2026. Breast Care (Basel) Thill M, Müller V, Fehm T, Albert US, Banys-Paluchowski M, Bartsch R, Bauerfeind I, Bjelic-Radisic V, Blohmer J, Dall P, Fallenberg EM, Fasching PA, Friedrich M, Gluz O, Harbeck N, Hartkopf A, Heil J, Hörner-Rieber J, Huober J, Janni W, Kreipe HH, Krug D, Kühn T, Kümmel S, Loibl S, Lüftner D, Lux MP, Maass N, Mundhenke C, Reinisch M, Reimer T, Rhiem K, Rody A, Schmidt M, Schneeweiss A, Schütz F, Sinn HP, Solbach C, Solomayer EF, Stickeler E, Untch M, van Mackelenbergh M, Witzel I, Wöckel A, Würstlein R, Ditsch N, Park-Simon TW. PMID: 42238803 [PubMed - as supplied by publisher]
	Low Frequency of Pathogenic Variants in BRCA1 Exons 11/20 and BRCA2 Exon 11 Suggests Divergent Mutational Hotspots in Sudanese Breast Cancer Patients: A Case-Control Study. Breast Cancer (Auckl) Abass Eltaib Ahmed H, Gorish BMT, Mahjaf GM, Abdelmula WIY, Elimam AA, Altayb HN, Dawood M, Zeen AAM, Altaher TAA, Ahmed EBA, Abdalla RE. PMID: 42238800 [PubMed]
	A Retrospective Cohort Study of Uterine Cancer Epidemiological Analysis and Age-Based Disparities in Saudi Arabian Population across 32 Years. Saudi Med J Alshehre SM, Althubiti MA. PMID: 42238215 [PubMed - in process]
	Impact of Germline BRCA1/2 Mutations on Clinical Outcomes in Metastatic Triple-Negative Breast Cancer Patients Treated with Sacituzumab Govitecan-An International CEBCC Study from Poland, the Czech Republic and Slovakia. Oncol Res Pacholczak-Madej R, Püsküllüo, Polakiewicz-Gilowska A, Pieni, Kolá, Malej, Ru, Holánek M, Soumarová R, Winsko-Szcz, , Konieczna A, M, Krej, Danielewicz I, Szymanik-Resko M, Ciszewski T, Lisik-Habib M, P, , , Czartoryska-Ar, , Smok-Kalwat J, Jarz, Biel, Kubeczko M. PMID: 42238016 [PubMed - in process]
	Multiparametric whole-body magnetic resonance imaging in breast cancer management: A prospective study. Tumori Palleschi M, Merloni F, Prochowski Iamurri A, Scarpi E, Diano D, Gianni C, Barone D, Di Menna G, Casadei C, Maltoni R, De Giorgi U, Musolino A, Rossi A. PMID: 42237676 [PubMed - as supplied by publisher]
	Possible selection bias in Mendelian randomization studies: effect of body mass index on breast cancer as an example. Am J Epidemiol Fei K, Teasdale CA, Terry MB, Schooling CM. PMID: 42237572 [PubMed - as supplied by publisher]
	The role of circulating tumor DNA in ovarian cancer. Discov Oncol Abulajiang Y, Ming W, Wu Y. PMID: 42237054 [PubMed - as supplied by publisher]
	Comparative efficacy of exercise modes on inflammatory cytokines in patients with breast cancer: a systematic review with pairwise and network meta-analyses. Sci Rep Khalafi M, Sakhaei MH, Ghasemi F, Fatolahi S, Omidian K, Symonds ME, Rohani H, Rosenkranz SK, Suzuki K, Zakeri AS, Mohammadiyan M, Mojtahedi S, Maleki AH, Rafiei H. PMID: 42236844 [PubMed - as supplied by publisher]
	Breast cancer in Bosnia and Herzegovina: real-world patterns of diagnosis, treatment, and survival outcomes. Sci Rep Be, Sokolovi, Ceri, Pa, Grebo A, Alji, Mattar L, Freedman C, Doroshenko O, Mandrik O. PMID: 42236771 [PubMed - as supplied by publisher]
	Providers' perspectives on implementing alert-based patient-reported outcome monitoring for stage IV breast cancer. J Patient Rep Outcomes Breidenbach C, Hage AM, Schellack SK, Pross T, Dordevic AD, Kowalski C, Karsten MM. PMID: 42236639 [PubMed - as supplied by publisher]
	Combining Node-RADS with ADC can improve diagnostic performance for lymph node metastasis in breast cancer. Eur Radiol Han L, Jia N, Wang H, Zhang W, Luo Y, Huang B, Liu G, Ye D, Wang X, Dong Y. PMID: 42236540 [PubMed - as supplied by publisher]
	Contralateral breast cancer risks for BRCA1, BRCA2, PALB2, CHEK2, and ATM pathogenic variant carriers in two large cohort studies. BJC Rep Allen I, Whish N, Yadav S, Boddicker NJ, Drukker C, van de Beek I, Eccles DM, Turnbull C, Pharoah P, Antoniou AC, Easton DF, Couch FJ, Schmidt MK, Tischkowitz M. PMID: 42236538 [PubMed]
	Is molecular breast imaging suitable for use in UK breast cancer pathways? A qualitative study exploring healthcare professionals' perspectives. BMJ Open Elliott H, Allen AJ, Forester ND, Graziadio S, Jones WS, Lendrem C, Pearce M, Powell T, Bray A, Scott J. PMID: 42236092 [PubMed - in process]
	Updates on Breast Cancer Screening and Special Considerations for Transgender Men and Women. Obstet Gynecol Clin North Am Tewari S, Hall MF. PMID: 42236072 [PubMed - in process]
	Adjuvant chemotherapy in stage I triple-negative breast cancer: A systematic review and meta-analysis of survival outcomes. Cancer Treat Rev Jacobs F, Polymeropoulos A, Monte M, Ligorio F, Provenzano L, Armani G, Fotia G, Mazzoli G, Coppola G, Bottelli A, Iacobucci A, Bianchessi V, Abate A, Bianchi GV, Capri G, Ferraris C, Martelli G, Folli S, Vingiani A, Pruneri G, Miceli R, Vernieri C. PMID: 42235455 [PubMed - as supplied by publisher]
	Genomic instability in canine mammary tumors: A comparative focus on loss of heterozygosity and microsatellite alterations with human breast cancer. Mutat Res Rev Mutat Res Khand FM, Jatoi BA, Lakho SA, Leghari A. PMID: 42235400 [PubMed - as supplied by publisher]
	Associations between molecular classification and response to intra-uterine levonorgestrel device therapy in patients with medically managed endometrial cancer and endometrial intra-epithelial neoplasia: a multi-center Endometrial Cancer Molecularly Targeted Therapy (ECMT2) Consortium study. Int J Gynecol Cancer Nolin A, Brown MD, Thomas SM, Strickland KC, Bean S, Neff JL, Pothuri B, Moore KN, Mullen M, Clark LH, Konecny G, Jackson AL, Ko EM, Whitaker R, Linhart S, March L, Hacker K, Washington C, Thaker P, Maxwell GL, Berchuck A, Secord AA, Previs RA. PMID: 42235254 [PubMed - as supplied by publisher]
	Self-managed non-pharmacological interventions for post-treatment upper limb dysfunction rehabilition among breast cancer survivors: A systematic review. Eur J Oncol Nurs Li J, Tan JB, Wang T, Wang H, Li M, Sharma S, Deravin L, Terry D. PMID: 42235206 [PubMed - as supplied by publisher]
	Real-world use of neratinib as extended adjuvant therapy in HER2-positive early-stage breast cancer: a multicentre study in mainland China and Hong Kong. Breast Abudureheiyimu N, Jia Y, Peng Z, Shi Y, Liu Q, Wang H, Zhou Y, Wang H, Wang K, Hu H, Liu Z, Chen W, Ng TY, Guo Z, Ren Z, Zhen H, Fan Y, Xu B. PMID: 42235181 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 329639

Seite 1 von 16482

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung